Brief: Pulmatrix Announces Cross License Agreement And Transfer Of Laboratory To Mannkind Corporation
29/05/2024 13:57
May 29 (Reuters) - MannKind Corp MNKD.O :
* PULMATRIX ANNOUNCES CROSS LICENSE AGREEMENT AND TRANSFER
OF
LABORATORY TO MANNKIND CORPORATION
* PULMATRIX INC - ASSUMPTION OF OUR LEASE AND LABORATORY BY
MANNKIND HELPS EXTEND OUR CASH RUNWAY FURTHER INTO 2026
* PULMATRIX INC - AS PART OF TRANSACTION, MANNKIND WILL
ASSUME
LEASE OF BEDFORD, MASS., RESEARCH AND DEVELOPMENT FACILITY
Source text for Eikon: ID:nPn35mnLza
Further company coverage: MNKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulmatrix
See all newsBrief: Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger
Pulmatrix Q2 loss narrows on clinical development hold
Pulmatrix Q1 net loss narrows, clinical development on hold
Brief: Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger
NASDAQ RESUMED AT 09:00 AM